Miktaaz 500 Injection
Marketer
Zoxvina Biotech Private Limited
Salt Composition
Amikacin (500mg)
Overview Miktaaz 500 Injection
Ceftazidime 500mg Injection is a broad-spectrum antibiotic indicated for the prophylaxis and treatment of diverse bacterial infections. These can affect various body systems, including the urinary tract, musculoskeletal system (bones and joints), respiratory system (pneumonia), central nervous system, and bloodstream. Prophylactic use is common in hospitalized patients. Its mechanism of action involves inhibiting bacterial growth. Administration, strictly under medical supervision, is via intravenous infusion or intramuscular injection; self-administration is contraindicated. Consistent dosing at prescribed intervals is crucial; incomplete courses risk relapse or infection exacerbation. Frequently reported adverse reactions include local injection site reactions and elevated blood urea nitrogen levels. Persistent side effects or lack of clinical improvement warrant medical consultation. High-dose therapy may exceptionally result in vertigo, nephrotoxicity, and ototoxicity. Adherence to prescribed instructions is paramount, including regular monitoring of renal function, hearing, and urinalysis as directed. Pregnancy is a contraindication; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Miktaaz 500 Injection
Infections caused by bacteria
Major Benefits of Miktaaz 500 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Miktaaz 500 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Miktaaz 500 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Miktaaz 500 Injection works:
Miktaaz 500 Injection is a bacterial growth inhibitor, functioning as an antibiotic by blocking the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Miktaaz 500 Injection and alcohol presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Miktaaz 500 Injection during pregnancy poses a confirmed risk to fetal development, rendering its use inadvisable. Exceptions might exist in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Miktaaz 500 Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, thereby presenting no appreciable harm to the infant.
DrivingUNSAFE
Miktaaz 500 Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Miktaaz 500 Injection to individuals with impaired renal function. Dosage modification for Miktaaz 500 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Miktaaz 500 Injection appears safe for individuals with liver conditions. Preliminary findings indicate dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Miktaaz 500 Injection :
Omitting a scheduled dose of Miktaaz 500 Injection necessitates contacting your physician.
Facts to Know About Miktaaz 500 Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Active Class | Aminoglycoside antibiotics |
3,018 People bought this recently